This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with excess body weight and obstructive sleep apnoea not treated wi…

ObesityOverweightObstructive Sleep Apnoea

~Estimated

~$10 – $7,500

Novo Nordisk A/SNCT07571005

Phase 3

Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Obstructive Sleep Apnoea Treated With Positive Airway Pressure (AMAZE 4)

This study is being done to look at the efficacy and safety of NNC0487-0111 in participants with overweight or obesity, and obstructive sleep apnoea treated wi…

ObesityOverweightObstructive Sleep Apnoea

~Estimated

~$10 – $7,500

Novo Nordisk A/SNCT07571109